It will be held on May 27th 2024 from 10am to 3:30pm, in the amphitheatre of the Bordeaux Biologie Santé (BBS) building, Campus Carreire.
Precision medicine in oncology hinges on targeting specific cell surface markers to hit tumor cells while sparing healthy tissue. Some of the known markers not only identify the tumor cells but also contribute to cellular behavior. Their identification can be the opportunity to reach the tumor with specific toxic therapies and contribute advancing personalized cancer care.
This workshop gathers interdisciplinary experts who will share their knowledge and latest research on different ways to target tumor cell surface.
In order to organise the day as effectively as possible, and in particular the lunch, please register before May 10, 2024. Registration is free but compulsory.
Program
Welcome coffee, 9h30-10h00
Introduction, 10h00-10h15
- Julie Déchanet-Merville (ImmunoConcEpT), NEWMOON leader : the NEWMOON network
- Sandrine Dabernat (BRIC), Clément Morgat (INCIA), organisers : workshop presentation
Targeting using peptide mimetics, 10h15-12h15
- Isabelle Van Seuningen (ONCOLille, Canther) : peptide targeting mucins as RTK partners
- Annette Beck-Sickinger (Biochemistry and bioorganic chemistry, Leipzig University) : peptide targeting receptors
- Sebastien Lecommandoux (LCPO) : Biomimetic polypeptide-based nanoparticles
- Clément Morgat (INCIA) : peptide-based radionuclide targeting
Lunch break, 12h15-13h30
Targeting using antibodies mimetic, 13h30-15h30
- Vincent Aucagne (CBM, Orléans University) : affibodies targeting receptors
- Sebastian Kobold (LMU, Munich University) : Single cell RNA sequencing guided identification of target structures for CAR T cell therapiesCAR-T cells present and future
- Nicolas Larmonier (ImmunoConcEpT) : targeting the CTCs
- Sandrine Dabernat (BRIC) : lentivirus onco-pseudotyping
- Jeanne Leblond Chain (ARNA) : Aptamers as multifunctional tools for targeting drugs